###begin article-title 0
Aryl hydrocarbon receptor nuclear translocator (ARNT) gene as a positional and functional candidate for type 2 diabetes and prediabetic intermediate traits: Mutation detection, case-control studies, and gene expression analysis
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 234 239 234 239 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ARNT </italic>
###xml 92 97 <span type="species:ncbi:9606">human</span>
ARNT, a member of the basic helix-loop-helix family of transcription factors, is located on human chromosome 1q21-q24, a region which showed well replicated linkage to type 2 diabetes. We hypothesized that common polymorphisms in the ARNT gene might increase the susceptibility to type 2 diabetes through impaired glucose-stimulated insulin secretion.
###end p 3
###begin title 4
Methods
###end title 4
###begin p 5
###xml 81 86 81 86 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ARNT </italic>
###xml 497 502 497 502 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ARNT </italic>
We selected 9 single nucleotide polymorphisms to tag common variation across the ARNT gene. Additionally we searched for novel variants in functional coding domains in European American and African American samples. Case-control studies were performed in 191 European American individuals with type 2 diabetes and 187 nondiabetic European American control individuals, and in 372 African American individuals with type 2 diabetes and 194 African American control individuals. Metabolic effects of ARNT variants were examined in 122 members of 26 European American families from Utah and in 225 unrelated individuals from Arkansas. Gene expression was tested in 8 sibling pairs discordant for type 2 diabetes.
###end p 5
###begin title 6
Results
###end title 6
###begin p 7
###xml 213 218 213 218 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ARNT </italic>
###xml 295 296 295 296 <sub xmlns:xlink="http://www.w3.org/1999/xlink">g</sub>
###xml 472 477 469 474 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ARNT </italic>
No nonsynonymous variants or novel polymorphisms were identified. No SNP was associated with type 2 diabetes in either African Americans or European Americans, but among nondiabetic European American individuals, ARNT SNPs rs188970 and rs11204735 were associated with acute insulin response (AIRg; p =< 0.005). SNP rs2134688 interacted with body mass index to alter beta-cell compensation to insulin resistance (disposition index; p = 0.004). No significant difference in ARNT mRNA levels was observed in transformed lymphocytes from sibling pairs discordant for type 2 diabetes.
###end p 7
###begin title 8
Conclusion
###end title 8
###begin p 9
###xml 7 12 7 12 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ARNT </italic>
Common ARNT variants are unlikely to explain the linkage signal on chromosome 1q, but may alter insulin secretion in nondiabetic subjects. Our studies cannot exclude a role for rare variants or variants of small (< 1.6) effect size.
###end p 9
###begin title 10
Background
###end title 10
###begin p 11
###xml 522 523 522 523 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
Type 2 diabetes mellitus is a complex heterogeneous group of metabolic conditions characterized by elevated levels of serum glucose. Impairment in both hepatic and peripheral insulin action, and defective pancreatic insulin secretion characterize fully developed type 2 diabetes. The interaction between genetic risk factors and environmental or lifestyle factors likely account for the current rising prevalence of type 2 diabetes among many populations, including United States European Americans and African Americans [1].
###end p 11
###begin p 12
###xml 506 507 495 496 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 534 535 523 524 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 637 642 626 631 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ARNT </italic>
###xml 743 748 732 737 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ARNT </italic>
###xml 866 871 849 854 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ARNT </italic>
###xml 1038 1039 1021 1022 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 1196 1201 1179 1184 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ARNT </italic>
###xml 1420 1421 1403 1404 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 1499 1500 1479 1480 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 843 847 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
###xml 1015 1020 <span type="species:ncbi:9606">human</span>
Aryl Hydrocarbon Receptor Nuclear Translocator (ARNT, also known as hypoxia inducible factor-1beta) is a member of the basic helix-loop-helix Per/AhR/ARNT/Sim (bHLH-PAS) family of transcription factors. ARNT and its interacting partners HIF1alpha, HIF2alpha, and AhR form heterodimeric complexes which are required for cellular responses to hypoxia and environmental toxins such as dioxin. ARNT complexes also directly regulate the expression of genes involved in glucose transport and glucose metabolism [2]. Recently, Gunton et al [3] implicated ARNT directly in impaired insulin secretion in type 2 diabetes by showing a 90% decrease ARNT messenger RNA in islets from diabetic individuals when compared to normal islets. Down-regulation of ARNT expression decreased the glucose stimulated insulin secretion in the Min 6 beta-cell line, and mice lacking beta-cell ARNT expression exhibited abnormal glucose tolerance, impaired glucose stimulated insulin secretion, and changes in islet gene expression similar to human type 2 diabetes [3]. These studies have implicated ARNT in the transcriptional regulation of genes required for optimal glucose-responsive insulin secretion, and thus suggest ARNT as a strong candidate gene for diabetes. A further role of ARNT in type 2 diabetes is suggested by its role as an obligate partner of several transcription factors involved in the response to toxins and hypoxic stress [4]. Hence, ARNT may integrate the genetic predisposition to beta-cell failure [5] with environmental insults leading to diabetes pathogenesis.
###end p 12
###begin p 13
###xml 4 9 4 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ARNT </italic>
###xml 245 246 245 246 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 307 312 307 312 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ARNT </italic>
###xml 420 425 420 425 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ARNT </italic>
###xml 612 617 612 617 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ARNT </italic>
###xml 715 716 715 716 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 964 969 964 969 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ARNT </italic>
###xml 1223 1228 1223 1228 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ARNT </italic>
###xml 1368 1371 1368 1371 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cis</italic>
###xml 1464 1469 1464 1469 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ARNT </italic>
###xml 28 33 <span type="species:ncbi:9606">human</span>
The ARNT gene is located on human chromosome 1q21.2, a region with well replicated linkage to type 2 diabetes by us in European American and African American populations, and by others in European American, Chinese, and Pima Indian populations [6]. Thus, in addition to being a strong functional candidate, ARNT is a strong positional candidate gene for type 2 diabetes. We hypothesized that common polymorphisms in the ARNT gene would alter its function or expression, and in turn increase the susceptibility to diabetes by affecting glucose-stimulated insulin secretion. We evaluated the association of common ARNT sequence variants with type 2 diabetes by using HapMap phase2 linkage disequilibrium information [7] as well as by screening putative functional regions of the gene for sequence variants in European American and African American subjects, and by testing these variants for an association with type 2 diabetes. To examine the physiologic impact of ARNT variants, we studied 352 non-diabetic subjects who had undergone frequently sampled intravenous glucose tolerance tests, including members of families ascertained in Utah and unrelated European American subjects ascertained in Arkansas. We also examined ARNT expression in transformed lymphocytes as a surrogate tissue using a discordant sib pair design, and we searched for additional evidence for cis-acting regulatory sequence polymorphisms that would alter the mRNA expression ratio between ARNT alleles.
###end p 13
###begin title 14
Methods
###end title 14
###begin title 15
Study subjects
###end title 15
###begin p 16
###xml 73 74 73 74 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 444 445 444 445 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 446 447 446 447 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 294 302 <span type="species:ncbi:9606">patients</span>
###xml 1823 1835 <span type="species:ncbi:9606">participants</span>
###xml 2033 2038 <span type="species:ncbi:9606">women</span>
###xml 2085 2088 <span type="species:ncbi:9606">men</span>
Phenotypic features of our study populations are summarized in the Table 1. Case-control studies with type 2 diabetes were conducted primarily in two samples: a European American cohort of 191 diabetic subjects and 187 control subjects, and in an African-American cohort of 372 type 2 diabetic patients and 194 control individuals. European American individuals were ascertained in Utah for Northern European ancestry, as described previously [8,9], with additional control individuals ascertained in Arkansas for similar criteria. All African American individuals were ascertained in Arkansas. For all case-control cohorts, individuals with diabetes had known type 2 diabetes on pharmacological therapy, or had a documented high fasting glucose or diabetic glucose tolerance test. All diabetic individuals and had at least one other first degree relative with type 2 diabetes. Non-diabetic control individuals had no history of diabetes in a first degree relative and had either a normal 75 g oral glucose tolerance test or a normal fasting glucose level (below 5.6 mM). Replication of case-control association was performed in a European American cohort of 240 T2DM and 170 control subjects ascertained in Arkansas for similar selection criteria. Because of some overlap in controls with the initial case control study, the combined study size was 315 controls and 429 cases. All of our case individuals were recruited from diabetes clinics. African American diabetic individuals were recruited in large part from Department of Veterans Affairs diabetes clinics, resulting in a predominance of male diabetic individuals. Control individuals were recruited from spouses or family members of cases, by public advertisement, and by flyers posted in hospitals, clinics, and other public locations. Many control subjects were participants in other ongoing studies that recruited nondiabetic subjects without a family history of diabetes. Because female volunteers are in excess in most studies, our control population was skewed toward women whereas our case population was skewed toward men.
###end p 16
###begin p 17
Summary of Study Populations
###end p 17
###begin p 18
###xml 21 26 21 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ARNT </italic>
###xml 211 213 211 213 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 214 216 214 216 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 634 636 634 636 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
Metabolic effects of ARNT sequence polymorphisms were studied in two nondiabetic populations: a family based cohort of 122 non-diabetic members from 26 families of Northern European descent ascertained in Utah [10,11], and a European American population of 225 unrelated nondiabetic subjects ascertained in Arkansas with age under 60 years. All Utah family members underwent a tolbutamide - modified, frequently sampled intravenous glucose tolerance test (FSIGT). Because tolbutamide became unavailable during the study, 100 subjects had tolbutamide modified tests, whereas the remainder had an insulin modified (0.04 unit/kg) FSIGT [11]. All subjects provided written, informed consent under a protocol approved by the Institutional Review Board of either the University of Utah Health Sciences Center or the University of Arkansas for Medical Sciences.
###end p 18
###begin title 19
Genetic analysis
###end title 19
###begin p 20
###xml 4 9 4 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ARNT </italic>
###xml 86 87 86 87 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 178 179 178 179 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 189 194 189 194 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ARNT </italic>
###xml 415 417 415 417 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 439 441 439 441 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2 </sup>
###xml 461 462 459 460 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 661 662 659 660 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 794 796 792 794 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2 </sup>
###xml 854 859 850 855 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ARNT </italic>
###xml 907 908 903 904 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 913 914 909 910 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 1083 1084 1079 1080 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 30 35 <span type="species:ncbi:9606">human</span>
The ARNT gene spans ~67 kb of human chromosome1q21.2 and consists of 22 exons (Figure 1). We examined 74 single nucleotide polymorphisms (SNPs) from the August 2006 HapMap data [7] for the ARNT gene and 2 kb of surrounding sequence. We identified 17 SNPs that were both polymorphic and had minor allele frequencies over 5%, from which we selected 9 tagSNPs using the TAGGER program as implemented in HaploView 3.2 [12] with parameters of r2 </= 0.9 (see Figure 2). Similarly, from 75 HapMap SNPs reported in the Yoruban population of West Africa (Nigerian), we identified 18 SNPs that were both polymorphic and had a minor allele frequency exceeding 5% (Figure 3). We forced the inclusion of the 3 SNPs that were also polymorphic in European Americans, and identified an additional 7 tagSNPs (r2 </= 0.9, TAGGER program) to cover common variation in the ARNT gene in an African-American population (Figures 2 and 3). SNPs were genotyped by Pyrosequencing (PSQ96, Biotage AB, Uppsula, Sweden) using a modification of manufacturer's protocol that used a biotinylated universal primer [9]. SNPs showing an association with type 2 diabetes in the initial Northern European case-control cohort were genotyped in a confirmatory Arkansas European American case-control cohort. Associated SNPs and any SNPs with a minor allele frequency over 10% in European Americans were also tested for an association with quantitative prediabetic traits in non-diabetic individuals.
###end p 20
###begin p 21
###xml 17 22 17 22 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ARNT </italic>
###xml 0 56 0 56 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Structure of the <italic>ARNT </italic>gene and location of SNPs analyzed</bold>
Structure of the ARNT gene and location of SNPs analyzed. The approximate location of all 22 reference sequence exons is shown as black bars, and the large variable 3'UTR region is shown as hatched box. The location of the SNPs is shown as arrows below the schematic. Linkage disequilibrium relationships are shown in Figure 2 and 3.
###end p 21
###begin p 22
###xml 0 70 0 70 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Linkage disequilibrium pattern of the ARNT region based on HapMap data</bold>
###xml 408 410 408 410 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2 </sup>
Linkage disequilibrium pattern of the ARNT region based on HapMap data. Markers selected for genotyping in our case-control cohorts are marked by an asterisk (*). The top portion of each diagram shows the known exon-intron structure. Only SNPs with a minor allele frequency over 5% in HapMap data were selected to construct the linkage disequilibrium map. Figure 2 shows linkage disequilibrium based on the r2 statistic using Hapmap Caucasian (CEPH) data.
###end p 22
###begin p 23
###xml 0 82 0 82 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Linkage disequilibrium pattern of the ARNT region based on HapMap data in Yorubans</bold>
Linkage disequilibrium pattern of the ARNT region based on HapMap data in Yorubans. Figure 3 is identical to Figure 2, except shown in Yorubans for selection of SNPs in African Americans. Asterisks (*) identify markers selected for genotyping.
###end p 23
###begin title 24
Screening for novel variants
###end title 24
###begin p 25
###xml 28 33 28 33 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ARNT </italic>
###xml 1043 1055 <span type="species:ncbi:9606">participants</span>
Given the large size of the ARNT gene, we focused the screening for novel variants on the known major functional domains: the DNA binding basic helix loop helix (bHLH) domain (amino acid residues 103-143); the dimerization (PAS) domain (amino acid residues 161-235 and 349-419); and the transactivation domain at the carboxyl terminal. Primers were designed for amplicons of under 600 bp using sequence NM_001668 and the University of California Santa Cruz (genome.ucsc.edu) genome and proteome browsers for exons 1 (amino terminal), 6 (bHLH domain), 7 (PAS domain 1), 12-13 (PAS domain 2), and 22 (transactivation domain). Additionally, the flanking intronic sequences, 5' untranslated region, and 272 bp of the 3' untranslated region were screened. Fragments were screened using denaturing high-performance liquid chromatography (DHPLC) on a Transgenomic WAVE HT DNA fragment analysis system (Transgenomic Inc., Omaha, NE) in 24 European American and 24 African American individuals, each population comprising 16 diabetic and 8 nondiabetic participants. Variant chromatographic patterns were characterized by dideoxy DNA sequencing. The 2 kb region 5' to the transcription start site, which was non amenable to DHPLC screening, was sequenced directly in the same 48 individuals (Polymorphic DNA Technologies, Inc.; Alameda, CA).
###end p 25
###begin title 26
Gene expression
###end title 26
###begin p 27
###xml 507 512 507 512 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ARNT </italic>
Transformed lymphocytes from 8 sibling pairs discordant for type 2 diabetes were grown under normoglycemic (5.6 mM glucose) conditions, then exposed to either 5.6 mM glucose, or 28 mM glucose and 5 nM insulin for 8 hours before harvest. Total RNA was extracted using RNEasy mini kit (Qiagene Inc., Valancia, CA), the quantity and quality checked using an Agilent 2100 Bioanalyzer, and 600 ng reverse transcribed using random hexamer primers (TaqMan Reverse Transcription Reagents, Applied Biosystems, Inc). ARNT expression was measured by real time PCR on a Rotorgene 2000 Real time-PCR system (Corbett Life Science, Sydney Australia), with 18S ribosomal RNA as a normalization standard. Primer sequences were as follows: 18S forward: ATCAACTTTCGATGG TAGTCG, 18S reverse: TCCTTGGATGTGGTAGCCG, ARNT - Forward: TTCATCCCATACTCAAAATACCC, ARNT - Reverse: AAAGCAAAACCCAATCTCAA.
###end p 27
###begin title 28
Allelic expression imbalance
###end title 28
###begin p 29
###xml 22 27 22 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ARNT </italic>
###xml 62 66 62 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cis </italic>
###xml 254 256 254 256 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
Unequal expression of ARNT alleles was sought as evidence for cis acting regulatory variants by comparing peak heights in individuals heterozygous for the synonymous coding SNP rs2228099 or 3' untranslated SNP rs10847, using methods described elsewhere [13]. Briefly, total RNA was reverse transcribed using random hexamers. Allelic specific quantitation of both cDNA and genomic DNA samples was determined using the same assay for pyrosequencing on a PSQ 96 Pyrosequencer (Biotage, Inc, Uppsala, Sweden), with peak height quantified using Allele Quantification software (Biotage, Inc).
###end p 29
###begin title 30
Statistical analysis
###end title 30
###begin p 31
###xml 192 194 192 194 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 292 294 292 294 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 375 376 375 376 <sub xmlns:xlink="http://www.w3.org/1999/xlink">g</sub>
###xml 601 602 601 602 <sub xmlns:xlink="http://www.w3.org/1999/xlink">g</sub>
###xml 647 648 647 648 <sub xmlns:xlink="http://www.w3.org/1999/xlink">I</sub>
###xml 766 768 766 768 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 769 771 769 771 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 858 859 858 859 <sub xmlns:xlink="http://www.w3.org/1999/xlink">I</sub>
###xml 975 977 972 974 <sub xmlns:xlink="http://www.w3.org/1999/xlink">I </sub>
###xml 981 982 978 979 <sub xmlns:xlink="http://www.w3.org/1999/xlink">g</sub>
###xml 985 987 982 984 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 988 990 985 987 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 1043 1044 1040 1041 <sub xmlns:xlink="http://www.w3.org/1999/xlink">I</sub>
###xml 1049 1050 1046 1047 <sub xmlns:xlink="http://www.w3.org/1999/xlink">g</sub>
Allele frequencies in case and control populations were compared using Fisher Exact and Cochran-Armitage Trend tests. Hardy-Weinberg equilibrium was tested using the online DeFinetti program [14]. Linkage Disequilibrium and haplotype association analyses were performed by Haploview v. 3.32 [12]. Insulin secretion was calculated as the acute insulin response to glucose (AIRg), determined either as the mean excursion over baseline from 2-10 min (Utah population) or the 2 min - 10 min Area Under Curve (AUC; Arkansas population). Although they give different values, the two methods of computing AIRgare highly correlated. Insulin sensitivity (SI) was calculated from the FSIGT using either the MinMod (Utah sample) or MinMod Millenium (Arkansas Sample) programs [15,16]. The two programs use the same algorithms and provide nearly identical estimates of SI. The ability of the beta-cell to compensate for insulin sensitivity was determined by the disposition index (DI = SI *AIRg) [17,18]. Genotypic effects on glucose homeostasis traits (SI, AIRg, DI) were tested using mixed effect, general linear regression models implemented in SPSS v.12 for Windows (SPSS Inc., Chicago, IL). Skewed variables were ln-transformed to normality prior to analysis, and age, body mass index (BMI), gender, genotype, protocol (tolbutamide or insulin), and diagnosis (IGT or glucose tolerant) were included as factors and covariates, as appropriate. Pedigree membership was included as a random factor in analyses of family-based Utah samples.
###end p 31
###begin p 32
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ARNT </italic>
###xml 334 339 334 339 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ARNT </italic>
ARNT expression was normalized to 18S RNA and both pair-wise and group-wise differences compared using the nonparametric Mann-Whitney U and Wilcoxan signed rank tests. For allelic expression imbalance, we computed the 95% CI for the assay from DNA (expected ratio 1:1). We considered allelic expression imbalance to be present if the ARNT RNA ratio fell outside the 95% CI for DNA in heterozygous individuals. The significance for the number of samples falling outside the 95% CI was determined using a chi-square goodness of fit test.
###end p 32
###begin title 33
Power considerations
###end title 33
###begin p 34
We calculated the power assuming p < 0.05 and for odds ratios over 1.5 (approximately that of TCF7L2) using allelic association (approximately the same as the Cochran Armitage trend test). We considered a control minor allele frequency range of 0.1 to 0.4. Among our primary European American population, we had 70% power at an odds ratio of 1.7 for a minor allele frequency of 0.1, or over 70% power for an odds ratio of 1.6 or greater for a minor allele frequency of 0.15 - 0.25, and over 70% for a minor allele frequency over 0.25 at an odds ratio of 1.5. Among African Americans, our power exceeded 70% for an odds ratio over 1.5 at minor allele frequencies over 0.15, but would have required an odds ratio of 1.6 for 70% power at a minor allele frequency of 0.1.
###end p 34
###begin title 35
Results
###end title 35
###begin title 36
Association with type 2 diabetes
###end title 36
###begin p 37
###xml 94 95 94 95 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 135 136 135 136 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T3">3</xref>
###xml 434 436 434 436 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2 </sup>
###xml 463 465 463 465 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2 </sup>
###xml 640 641 640 641 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T3">3</xref>
###xml 827 828 827 828 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T3">3</xref>
Results of both European American and African American association studies are shown in Table 2, with raw genotype data shown in Table 3. No individual SNP was associated with type 2 diabetes in either population, with the best trend for rs10305685 in African Americans (p = 0.067; OR = 0.75). In the European American case-control study, SNPs rs2134688 (intron 4) and rs4379678 (3'flanking) were in complete linkage disequilibrium (r2 = 1) despite selection on r2 < 0.9. Excess homozygosity for the minor allele was observed in controls for both SNPs, with evidence for a protective effect of the rare homozygous alleles (p = 0.006; Table 3). We expanded SNP rs2134688 into an independent European American case-control cohort ascertained in Arkansas, where no trend to an association with type 2 diabetes was observed (Table 3).
###end p 37
###begin p 38
Summary of single nucleotide polymorphisms and allele frequencies
###end p 38
###begin p 39
###xml 349 351 349 351 <sup xmlns:xlink="http://www.w3.org/1999/xlink">1 </sup>
###xml 352 354 352 354 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2 </sup>
###xml 374 375 374 375 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 378 380 378 380 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2 </sup>
###xml 400 402 400 402 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3 </sup>
Position is given relative to the A of the ATG start site. Genome location is based on the March 2006 (hg18) build. Variant is given for the negative (coding) strand as major/minor allele in Caucasian samples. Frequencies are given for the minor allele in Caucasian and African American samples. NP, not polymorphic in HapMap dataset; ND, not done. 1 r2 = 1 with rs2134688; 2, r2 = 1 with rs1889740; 3 minor allele is "G" in African Americans.
###end p 39
###begin p 40
###xml 49 54 49 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ARNT </italic>
Raw counts of cases and controls by genotype for ARNT region SNPs in Caucasians and African Americans
###end p 40
###begin p 41
Position is shown relative to ATG start site. Variants are shown for the major/minor allele, as genotyped. Populations are as described in Table 1: UT, Utah Caucasian; AR, Arkansas Caucasian; AA, African-American. The total number of samples genoytped varies due to genotyping success rates, and may differ from the totals in Table 1.
###end p 41
###begin p 42
###xml 17 22 17 22 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ARNT </italic>
###xml 287 289 287 289 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2 </sup>
###xml 763 765 763 765 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2 </sup>
Screening of the ARNT gene for additional variants identified a single synonymous SNP in exon 7, previously reported as rs2228099. Our selected tagSNP rs1889740, which showed no association with type 2 diabetes in European American or African American populations, was a perfect proxy (r2 = 1) in both HapMap CEPH and Yoruban populations. We confirmed the strong linkage disequilibrium in 120 European American individuals. We confirmed also the presence of common SNPs rs7517566 in the 5' flanking region, rs35756904 in the 5' untranslated region, rs10305650 in intron 1, rs2256355 and rs1027699 in intron 6, rs3738483 and rs3768017 in intron 12,, and rs10305749 in the 3' untranslated region. Each common variant was typed directly or tagged by a typed SNP at r2 > 0.9, and neither the typed SNPs nor excellent proxies were associated with type 2 diabetes. We also identified a very rare SNP (rs7515228; 1 heterozygous individual in 48 samples) in the 5' flanking region, which was not typed due to low power in our population.
###end p 42
###begin p 43
###xml 173 175 173 175 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 302 303 302 303 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T4">4</xref>
###xml 652 653 652 653 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T5">5</xref>
In European Americans, 8/9 SNPs were confirmed to have a minor allele frequency over 5%, and all 8 SNPs fell within a single block using the solid spline block definitions [12]. The 8 SNPs defined 7 common haplotypes, of which none differed significantly in frequency between cases and controls (Table 4). Similarly, among the African American population all 10 tagSNPs fell within a single block. Haplotype "CTGTTCGCAC" was more common among controls (6.7%) than among cases (3.6%), as was a 4 marker sliding window (ATAC; 50.3% in cases vs 43.8% in controls, p = 0.038). Neither nominal association remained significant on permutation testing (Table 5).
###end p 43
###begin p 44
Haplotype Frequencies for ARNT SNPs in Utah Caucasian Cases and Controls
###end p 44
###begin p 45
The 8 marker haplotypes are shown for all markers with minor allele frequency over 5%. The bases are shown according to the assay and may be the complement to the nucleotide in the public database. The SNPs included were rs4379678, rs10847, rs10305724, rs1889740, rs10305714, rs10305710, rs2134688, rs11204735.
###end p 45
###begin p 46
Haplotype frequencies for ARNT SNPs in African American cases and controls
###end p 46
###begin p 47
Four marker haplotypes are shown using markers rs10305685, rs10305679, rs11204735, and rs7517566. Haplotypes are shown with the nucleotide as genotyped in the assay, which may differ from the nucleotide listed in public databases.
###end p 47
###begin title 48
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ARNT </italic>
ARNT SNPs and insulin secretion
###end title 48
###begin p 49
###xml 30 35 30 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ARNT </italic>
###xml 57 58 57 58 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 411 413 411 413 <sub xmlns:xlink="http://www.w3.org/1999/xlink">g </sub>
###xml 858 859 855 856 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T6">6</xref>
###xml 869 874 866 871 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ARNT </italic>
###xml 879 883 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
###xml 1054 1059 <span type="species:ncbi:9606">women</span>
###xml 1073 1076 <span type="species:ncbi:9606">men</span>
Based on the proposed role of ARNT in insulin secretion [3], we selected 4 SNPs that showed a trend to an association with type 2 diabetes or that had a minor allele frequency over 10% to test in two populations of nondiabetic European American individuals who had undergone detailed phenotyping of insulin sensitivity and secretion. Both rs188970 (p = 0.005) and rs11204735 (p = 0.002) were associated with AIRg in nondiabetic members of high risk Utah families. However, neither finding was replicated in and unrelated European American sample from Arkansas. Disposition index (DI), a measure of the ability of the beta-cell to compensate for insulin resistance, was associated with rs2134688 in unrelated individuals from Arkansas in interaction with both body mass index (p = 0.004) and age (p = 0.04). Marginal means for all analyses are shown in Table 6. Because ARNT null mice showed sexual dimorphism in effects on insulin secretion, we also tested for an interaction of genotype with gender. Rs2134688 showed a significantly lower mean DI among women (0.228) than men (4.822; p = 0.001) among Utah family members, but this interaction was not observed in individuals from Arkansas (data not shown).
###end p 49
###begin p 50
Marginal means for intravenous glucose tolerance measures
###end p 50
###begin p 51
###xml 182 184 182 184 <sub xmlns:xlink="http://www.w3.org/1999/xlink">g </sub>
###xml 319 321 319 321 <sub xmlns:xlink="http://www.w3.org/1999/xlink">g </sub>
###xml 564 565 564 565 <sub xmlns:xlink="http://www.w3.org/1999/xlink">I</sub>
###xml 620 622 620 622 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-1</sup>
###xml 627 628 627 628 <sub xmlns:xlink="http://www.w3.org/1999/xlink">g</sub>
###xml 765 767 765 767 <sub xmlns:xlink="http://www.w3.org/1999/xlink">I </sub>
###xml 772 773 772 773 <sub xmlns:xlink="http://www.w3.org/1999/xlink">g</sub>
###xml 825 827 825 827 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-2</sup>
###xml 931 933 931 933 <sub xmlns:xlink="http://www.w3.org/1999/xlink">g </sub>
###xml 969 971 969 971 <sub xmlns:xlink="http://www.w3.org/1999/xlink">I </sub>
###xml 974 977 974 977 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-5 </sup>
###xml 989 991 989 991 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-1</sup>
###xml 1086 1088 1086 1088 <sub xmlns:xlink="http://www.w3.org/1999/xlink">g </sub>
###xml 1104 1106 1104 1106 <sub xmlns:xlink="http://www.w3.org/1999/xlink">I </sub>
###xml 1111 1113 1111 1113 <sub xmlns:xlink="http://www.w3.org/1999/xlink">g </sub>
Marginal means are shown after adjustment for age, gender and BMI; significance is based on a general linear model and p values are shown without correction for multiple testing. AIRg in the Utah Caucasian study is from the mean 2-10 min post challenge insulin excursion in pmol/l; for Arkansas Caucasian study, the AIRg is taken from MinMod Millenium output and is the area under the curve from 0 to 10 min, converted to pmol/l. All means are transformed back to the linear scale from Ln-transformed values; 95% confidence intervals are provided in parenthesis. SI, insulin sensitivity index from MinMod in (pmol/l) min-1; AIRg, acute 2-10 min insulin response to intravenous glucose bolus, in pmol/l (UT sample) or pmol-min/l (AR sample); DI, Disposition index (SI x AIRg) has no units. Values from the Utah sample are x 10-2. Note that the MinMod Millenium program calculates disposition index using the area under curve for AIRg and without the decimal places for SI (10-5 (pmol/l) min-1. Because calculations in the Utah population used mean 2 min - 10 min insulin to calculate AIRg and calculated SI x AIRg values were calculated using the legacy MinMod program and Arkansas samples using the MinMod Millenium program, the values between populations are not directly comparable.
###end p 51
###begin title 52
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ARNT </italic>
ARNT gene expression
###end title 52
###begin p 53
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ARNT </italic>
###xml 211 216 211 216 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ARNT </italic>
###xml 271 274 271 274 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vs </italic>
ARNT mRNA levels in transformed lymphocytes did not differ between 8 European American control individuals and cell lines from their 8 type 2 diabetic siblings, either when grown under normoglycemic conditions (ARNT to 18 S RNA ratio 0.958, range 0.611-1.285 in controls vs 1.067, range 0.446 - 1.555 in diabetic cell lines; p = 0.40) or when cultured in 28 mM glucose and 5 nmol/l insulin (0.8131.067, range 0.449-1.164 in controls; 0.946, range 0.400 - 2.329 in type 2 diabetes; p = 0.67).
###end p 53
###begin p 54
###xml 28 31 28 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cis</italic>
###xml 83 88 83 88 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ARNT </italic>
###xml 271 272 271 272 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 825 826 825 826 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
We searched for evidence of cis-acting regulatory variants by testing the ratio of ARNT transcripts (cDNA) in transformed lymphocytes from European American and African American individuals who were heterozygous for the transcribed variants rs2228099 and rs10847 (Figure 4). We compared cDNA from 11 individuals at rs10847 to 154 DNA samples, and 23 cDNA samples at rs228099 to 63 DNA samples. Both SNPs showed some evidence of allelic expression imbalance, with 4/11 samples for rs10847 and 7/23 for rs228099 falling outside of the 95% confidence intervals for the allelic ratio set from the cDNA (p = 0.0001 and p = 0.001, respectively). At rs10847, samples showed allelic ratios of 1.6 to 3.0 (expected 1.14 from DNA), whereas deviations from expectations were modest for rs228099 (ratios 1.18-1.21, expected 1.07; Figure 4). A single sample at rs228099 showed a ratio in the opposite direction (ratio 0.41).
###end p 54
###begin p 55
###xml 83 88 83 88 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ARNT </italic>
###xml 0 92 0 92 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Allelic expression imbalance at 3'UTR (rs10847) and exonic (rs2228099) SNPs of the <italic>ARNT </italic>gene</bold>
Allelic expression imbalance at 3'UTR (rs10847) and exonic (rs2228099) SNPs of the ARNT gene. The scatter plot shows the allele specific expression in cDNA (big up tri, open) as compared to genomic DNA (â—‡) for 11 heterozygous samples at rs10847 (C/T) and 23 heterozygous samples at rs2228099 (C/G).
###end p 55
###begin title 56
Discussion
###end title 56
###begin p 57
###xml 297 298 286 287 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 473 474 455 456 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 546 547 528 529 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 695 705 677 683 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HNF4&#945; </italic>
###xml 753 755 731 733 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 789 794 767 772 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ARNT </italic>
###xml 857 862 835 840 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ARNT </italic>
###xml 1033 1038 1011 1016 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ARNT </italic>
###xml 881 886 <span type="species:ncbi:9606">human</span>
ARNT (or HIF1beta) is the obligate heterodimer for a family of bHLH-PAS transcription factors that include HIF1alpha, HIF2alpha and AhR. These proteins in turn mediate signal transduction in response to both hypoxia and environmental toxins, including dioxin and polycyclic aromatic hydrocarbons [3]. Recent data have also implicated ARNT in regulation of important downstream genes in the beta-cell, including HNF4alpha, IRS2, AKT2, and enzymes of the glycolytic pathway [3]. Indeed, putative ARNT binding sites may exceed 13,000 in the genome [3], and may include genes involved in glucose metabolism, vascular function, and oxygen transport (erythropoietin). Genes downstream of ARNT such as HNF4alpha may in turn bind to large numbers of promoters [19]. In addition to data supporting ARNT as a strong functional candidate gene for type 2 diabetes, the ARNT gene is located on human chromosome 1q21, a region with replicated linkage to type 2 diabetes in diverse populations. These facts suggested that genetic variants altering ARNT function or regulation would impact glucose homeostasis and diabetes risk. To test this hypothesis we searched for indirect evidence that SNPs marking common haplotypes were associated with type 2 diabetes or altered insulin secretion. We also searched directly for coding or highly conserved variants that might directly impact ARNT function.
###end p 57
###begin p 58
###xml 695 700 695 700 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ARNT </italic>
###xml 875 877 875 877 <sub xmlns:xlink="http://www.w3.org/1999/xlink">g </sub>
###xml 1442 1447 1442 1447 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ARNT </italic>
In the current study, we found no nonsynonymous SNPs that were likely to alter ARNT function. Based on HapMap data and our own genotyping, the selected tagSNPs should have adequately covered all common genetic variants. No SNP showed an allelic association with type 2 diabetes, either European American or African American individuals. Although we found associations of SNPs rs2134688 (intron 4) and rs4379678 (3' flanking region) under a recessive model, these findings could not be confirmed in a larger population and we believe the original observations, which were also out of Hardy Weinberg Equilibrium, were likely spurious and due to small sample size. We anticipated that variation in ARNT would alter insulin secretion, and we indeed found evidence for an association of SNPs rs188970 (a perfect proxy for synonymous SNP rs2228099) and rs11204735, with altered AIRg among members of high risk families. On the other hand, these findings were not replicated in a separate and differently ascertained population from Arkansas. The lack of replication may reflect differences in the two populations - one cohort of related individuals from high risk families, the other a more heterogeneous and unrelated population from Arkansas with more obese subjects and a very different environment. Alternatively, the observation in high risk families may have been spurious, as we tested 3 traits and 4 SNPs. However, the suspected biology of ARNT would suggest that environmental interactions may differ across populations. The same arguments apply for the interaction of SNP rs2134688 with gender to determine DI. Additional studies are needed to determine the role of these variants in insulin secretion.
###end p 58
###begin p 59
###xml 125 127 125 127 <sub xmlns:xlink="http://www.w3.org/1999/xlink">g </sub>
###xml 270 275 270 275 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ARNT </italic>
###xml 435 437 435 437 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 621 622 621 622 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
Replication of genetic associations, both with dichotomous traits such as type 2 diabetes and quantitative traits such as AIRg has been difficult with sample sizes that are practical for individual laboratories. We have sought alternative methods based on comparison of ARNT expression among siblings discordant for type 2 diabetes, and using allelic expression imbalance for transcribed SNPs to find evidence for regulatory variants [13]. In the current study, we examined two transcribed SNPs. In both cases, a few heterozygous individuals showed allelic imbalance outside of the range observed for genomic DNA (Figure 2), suggesting a possible regulatory mutation. Whether these results in transformed lymphocytes reflect expression in pancreatic beta-cells is unknown, and the two SNPs appear to give different results. Nonetheless, SNP rs2228099 is in strong linkage disequilibrium with the SNP rs188970 that was associated with altered insulin secretion.
###end p 59
###begin p 60
###xml 78 83 78 83 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ARNT </italic>
###xml 524 526 521 523 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 527 529 524 526 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 771 778 768 775 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TCF7L2 </italic>
###xml 784 786 781 783 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 992 994 989 991 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 1471 1478 1468 1475 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KCNJ11 </italic>
###xml 1546 1551 1539 1544 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PPARG</italic>
###xml 1657 1659 1650 1652 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 1660 1662 1653 1655 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 1663 1665 1656 1658 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
The strengths of this study are the use of multiple approaches to examine the ARNT gene, including association studies in two populations, quantitative trait studies for insulin secretion, and gene expression studies in transformed lymphocytes as a surrogate tissue for pancreatic beta-cells. Nonetheless, this study had several limitations. First, the association study was of modest size, and would have been unable to detect a role for variants with small effect. Recent genome wide association scans in type 2 diabetes [20-23] have suggested that most if not all loci had odds ratios (ORs) below 1.5 and generally near 1.2 or less. Whereas we had 70% power to detect an association for common SNPs with an OR in the range of 1.5-1.7, or the approximate effect of the TCF7L2 gene [24], we had very limited power to detect effects with an OR of 1.2 or less. Although data for most published genome wide association scans are not yet publicly available, the Diabetes Genome Initiative scan [23] data are publicly available, and show 3 SNPs in the ARNT gene that can be estimated to capture 50% of the genetic variation. As with our study, no SNP showed any trend to association in over 1400 cases and 1400 controls. Based on allelic association and p < 0.05, the two SNPs at 35% minor allele frequency had 87% power to exclude an odds ratio of 1.2 or greater. That effect size would be comparable to the role of known diabetes genes including the potassium channel gene KCNJ11 E23K variant, or peroxisome proliferator activating receptor gamma (PPARG) P12A variant, or more recently described variants that have required very large populations to confirm [20-23,25]. Hence, our failure to detect an association with type 2 diabetes in our more modest sample size (albeit with two separately examined study populations) probably did not result from SNPs of small effect size.
###end p 60
###begin p 61
###xml 194 199 194 199 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ARNT </italic>
###xml 404 409 404 409 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ARNT </italic>
Small effects on insulin secretion similarly would not have been detectable in populations of a size that could be examined with detailed phenotyping, as was done in our study. Thus, additional ARNT variants might have a small effect on insulin secretion that we did not detect, or might have an effect on aspects of insulin secretion that we did not measure. Finally, we did not exhaustively screen the ARNT gene for variants, but instead used a combination of screening conserved regions and indirect screening based on linkage disequilibrium relationships to test the common variants. Although unlikely, a causative SNP outside of the region screened and not in linkage disequilibrium with our tagSNPs might have gone undetected.
###end p 61
###begin title 62
Conclusion
###end title 62
###begin p 63
###xml 15 16 15 16 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 45 50 45 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ARNT </italic>
###xml 193 198 193 198 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ARNT </italic>
###xml 529 534 526 531 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ARNT </italic>
###xml 580 585 577 582 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ARNT </italic>
###xml 785 790 782 787 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ARNT </italic>
Gunton et al. [3] observed a 90% decrease in ARNT expression in pancreatic islets from type 2 diabetic individuals when compared with nondiabetic islets. In contrast, we found no difference in ARNT message in transformed lymphocytes from siblings with type diabetes and nondiabetic siblings. Our results may reflect the lack of correspondence of gene expression in transformed lymphocytes and beta-cells, or Gunton et al may have found expression changes that were secondary to hyperglycemia. Our data provide some evidence that ARNT variants may alter insulin secretion and that ARNT gene variants may alter transcript levels, but our findings are not compatible with the dramatic differences in transcript levels observed by Gunton et al. We suggest that such striking reductions in ARNT transcript levels in the diabetic pancreas are unlikely to be caused by genetic variants and thus not the direct cause of the insulin secretory defect that occurs early in type 2 diabetes and progresses throughout the disease.
###end p 63
###begin title 64
Competing interests
###end title 64
###begin p 65
The author(s) declare that they have no competing interests.
###end p 65
###begin title 66
Authors' contributions
###end title 66
###begin p 67
###xml 492 497 <span type="species:ncbi:9606">human</span>
SKD directed the project, was primarily responsible for data interpretation, SNP selection, sequence analysis, and gene expression in sibling pairs, and wrote the first draft of the manuscript. NKS performed genotype analysis. WSC assisted with genotyping and prepared all samples for analysis. HW performed allelic imbalance studies. SCE conceived the project design with SKD, performed all analyses of insulin secretion and sensitivity, oversaw and reviewed all other analyses, oversaw all human subject studies, performed all MinMod analyses, and prepared the final draft of the manuscript. All authors read and approved the final manuscript.
###end p 67
###begin title 68
Pre-publication history
###end title 68
###begin p 69
The pre-publication history for this paper can be accessed here:
###end p 69
###begin p 70

###end p 70
###begin title 71
Acknowledgements
###end title 71
###begin p 72
This work was supported by grants from NIH/NIDDK (DK039311 and DK54366), by the Research Service of the Department of Veterans Affairs, and by the American Diabetes Association. Insulin secretion studies in nondiabetic subjects were supported by grant M01RR14288 from National Center for Research Resources (NIH). We thank the Clinical Research Center nursing staff and laboratory for invaluable support in conducting these studies.
###end p 72
###begin article-title 73
The Genetic Basis of Type 2 Diabetes
###end article-title 73
###begin article-title 74
Regulation of mammalian O2 homeostasis by hypoxia-inducible factor 1
###end article-title 74
###begin article-title 75
###xml 91 96 <span type="species:ncbi:9606">human</span>
Loss of ARNT/HIF1beta mediates altered gene expression and pancreatic-islet dysfunction in human type 2 diabetes
###end article-title 75
###begin article-title 76
ARNT misbehavin' in diabetic beta cells
###end article-title 76
###begin article-title 77
Non-insulin-dependent diabetes mellitus - a genetically programmed failure of the beta cell to compensate for insulin resistance
###end article-title 77
###begin article-title 78
The search for type 2 diabetes susceptibility loci: the chromosome 1q story
###end article-title 78
###begin article-title 79
The International HapMap Project
###end article-title 79
###begin article-title 80
Linkage and Association Mapping of a Chromosome 1q21-q24 Type 2 Diabetes Susceptibility Locus in Northern European Caucasians
###end article-title 80
###begin article-title 81
Calsquestrin 1 (CASQ1) gene polymorphisms under chromosome 1q21 linkage peak are associated with type 2 diabetes in Northern European Caucasians
###end article-title 81
###begin article-title 82
Heritability of pancreatic beta-cell function among nondiabetic members of Caucasian familial type 2 diabetic kindreds
###end article-title 82
###begin article-title 83
Activating Transcription Factor 6 (ATF6) Sequence Polymorphisms in Type 2 Diabetes and Pre-Diabetic Traits
###end article-title 83
###begin article-title 84
Haploview: analysis and visualization of LD and haplotype maps
###end article-title 84
###begin article-title 85
Detection of Allelic Imbalance Using Pyrosequencing.Pyrosequencing
###end article-title 85
###begin article-title 86
DiFinetti Program: Tests for deviation from Hardy-Weinberg equilibrium and tests for association
###end article-title 86
###begin article-title 87
MINMOD: a computer program to calculate insulin sensitivity and pancreatic responsivity from the frequently sampled intravenous glucose tolerance test
###end article-title 87
###begin article-title 88
MINMOD Millennium: a computer program to calculate glucose effectiveness and insulin sensitivity from the frequently sampled intravenous glucose tolerance test
###end article-title 88
###begin article-title 89
Toward physiological understanding of glucose tolerance: minimal model approach
###end article-title 89
###begin article-title 90
###xml 89 94 <span type="species:ncbi:9606">human</span>
Quantification of the relationship between insulin sensitivity and beta-cell function in human subjects: evidence for a hyperbolic function
###end article-title 90
###begin article-title 91
Control of pancreas and liver gene expression by HNF transcription factors
###end article-title 91
###begin article-title 92
A genome-wide association study identifies novel risk loci for type 2 diabetes
###end article-title 92
###begin article-title 93
Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes
###end article-title 93
###begin article-title 94
A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants
###end article-title 94
###begin article-title 95
Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels
###end article-title 95
###begin article-title 96
Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes
###end article-title 96
###begin article-title 97
A variant in CDKAL1 influences insulin response and risk of type 2 diabetes
###end article-title 97

